Clinical Trials Directory

Trials / Completed

CompletedNCT04263415

The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity

The Effects of Semaglutide on Modulation of Taste Sensitivity, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Responses in Women With PCOS and Obesity: a Randomized, Single-blind, Placebo-controlled Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University Medical Centre Ljubljana · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to explore the effects of GLP-1 receptor agonist (GLP-1 RA) semaglutide on modulation of taste sensitivity, tongue tissue transcriptome, modulation of neural response in central reward processing regions and gastric emptying rate. In addition, we aim to investigate the associations between semaglutide induced modulation of taste sensitivity, neural responses and gastric emptying with changes in body mass, eating- behavioural pattern, food perception and food intake.

Conditions

Interventions

TypeNameDescription
DRUGSemaglutidesemaglutide inrun period of 4 weeks with 0.5mg/week s.c. followed by 1mg/week sc for 12 weeks
OTHERPlaceboonce-weekly injection with placebo pen for 16 weeks

Timeline

Start date
2019-11-02
Primary completion
2020-05-08
Completion
2021-10-31
First posted
2020-02-10
Last updated
2023-09-08

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT04263415. Inclusion in this directory is not an endorsement.